impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Full Papers

 

Associations between the SLC22A12 gene and gout susceptibility: a meta-analysis

1, 2, 3, 4, 5, 6

 

  1. Department of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, China.
  2. Department of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, China.
  3. Department of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, China.
  4. Department of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, China.
  5. Department of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, China.
  6. Department of Rheumatology and Immunology, The Second Xiangya Hospital of Central South University, Changsha, China. doctorlgh@163.com

CER10622
2018 Vol.36, N°3
PI 0442, PF 0447
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 29352852 [PubMed]

Received: 17/06/2017
Accepted : 25/09/2017
In Press: 15/01/2018
Published: 17/05/2018

Abstract

OBJECTIVES:
The aim of this study is to explore whether the polymorphisms of rs475688 and rs3825016 in the solute carrier family 22 member 12 (SLC22A12) gene are associated with the susceptibility to gout or hyperuricaemia.
METHODS:
Relevant studies were enrolled by searching databases systematically. The pooled odds ratios (ORs) with 95% confidence interval (CI) were used to evaluate the associations. Q-test and I2 statistics were used to evaluate the heterogeneity. Publication bias was evaluated using Begg’s funnel plots and Egger regression test.
RESULTS:
A total of 7 articles involving 1216 patients and 1844 healthy controls were included in this meta-analysis. Significant association was detected between rs475688 polymorphism and gout susceptibility in three genetic models (C vs. T: OR=1.464, 95% CI 1.078-1.989, p=0.015; CC+CT vs. TT: OR=2.028, 95% CI 1.488–2.763, p=0.000; CC vs. CT+TT: OR=2.226, 95% CI 1.746-2.838, p=0.000). Significant association was observed between rs3825016 polymorphism and hyperuricaemia susceptibility only in allelic comparison (C vs. T: OR=1.274, 95% CI 1.101-1.474, p=0.001).
CONCLUSIONS:
The rs475688 polymorphism is associated with gout susceptibility. The correlation between rs3825016 polymorphism of SLC22A12 and hyperuricaemia susceptibility is possible.

Rheumatology Article